Schafer Joshua
Zevra Therapeutics, Inc. · CCO
Schafer Joshua is listed in filings as CCO at Zevra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 4, 2026, including sale activity. Recent filings connect the profile to Zevra Therapeutics, Inc. (ZVRA). The current snapshot covers public activity from Feb 3, 2025 to Feb 4, 2026. Reported amounts are shown as $96.5K to $664.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $30k3.4k shares | SellJan 30, 2026 | $8.83 | $10.95 | |
| $83k10.5k shares | SellFeb 13, 2025 | $7.86 | $10.95 |